RNA polymerase II (RpoII) from C. elegans is 50% inhibited by 7 ng/ml of alpha-amanitin, whereas RpoIII is 50% inhibited by 80 g/ml and RNA polymerase is unaffected by 500 g/ml. Dominant mutations have been described in the gene for the large subunit of the enzyme from mammals (Lobban et al. (1976), Cell 8: 65-70), Drosophila ( Greenleaf et al. (1979), Cell 18: 613-622), and the worm (Sanford et al. (1983), J. Biol. Chem. 258: 12804-12809), which render the enzyme partially resistant to alpha-amanitin by decreasing binding of the drug. None of these mutations, however, confer the full resistance characteristic of animal RpoI. Using a selection technique which increases the permeability of worms to alpha-amanitin, Rogalski and Riddle (this issue) have obtained a derivative of a resistant (ama- 1
(m118)) strain that is super-resistant to alpha-amanitin. The new mutation (
m526) is also at the
ama-1 locus and maps very close to
m118 (Rogalski and Riddle, op. cit.) RpoII from the
ama-1(
m118m526) strain is labile to chromatography and cannot be separated in active form from RpoI and III. However, RNA polymerases I, II and III in wild-type nuclei have the same sensitivities to alpha-amanitin as the purified enzymes. These enzymes can, therefore, be distinguished in a nuclear run-off assay using appropriate DNA probes. Nuclei were isolated by the method of Dixon (WBG 9:3, 73-74) and allowed to incorporate alpha-[32P]-CTP in the presence of various concentrations of alpha-amanitin. Nuclear transcripts were hybridized to a Southern blot of restriction fragments from cloned genes. These included genes transcribed by RpoI (Ascaris rDNA obtained from K. Bennett), RpoIII (C. elegans 5S DNA ( Honda et al. (1986), Nucl. Acids Res. 14: 869-881), and RpoII (C. elegans splice leader precursor DNA (Honda et. al., op.cit.; Krause and Hirsh (1987), Cell 49: 753-761)). Splice-leader precursor is transcribed in nuclei by RNA polymerase II (M. Golomb and S. Bektesh, unpublished). In this assay, transcription of splice-leader precursor RNA was unaffected by 500 g/ml alpha-amanitin, a concentration at which 5S RNA transcription was nearly completely inhibited. Thus, the
m526 mutation appears to render RpoII fully resistant to alpha-amanitin.